Introduction
============

Mastitis is considered to be the most prevalent and costly disease of dairy cow, which is caused by a variety of pathogens including the Gram-negative bacterium *E. coli* and the Gram-positive bacterium *S. aureus* [@B1], [@B2]. Most cases of *E. coli* mastitis present as an acute and severe infection, which can be either naturally cleared by the immune system or through antibiotic therapy if initiated within 10 days of the time of infection [@B3]. In contrast, *S. aureus* causes a persistent and chronic infection, which may range from mild to severe, with antibiotic treatment being largely ineffective [@B4], suggesting a different molecular pathogenesis.

Revealing the mechanisms of host immune and inflammatory responses to infection is particularly important for the prevention and treatment of mastitis. Previous studies have reported that the immune responses of bovine mammary epithelial cells (bMECs) infected with*E. coli* and *S. aureus* are significantly different [@B3], [@B5]. Furthermore, differential expression of inflammatory cytokines and other immune related proteins, in response to *E. coli* or *S. aureus*, were also detected in mammary tissues and milk [@B6]-[@B8].

MicroRNAs (miRNAs), endogenous and small non-coding RNA molecules, act as post-transcriptional regulators of gene expression by directly binding to the 3´ untranslated region (UTR) of target mRNA. Recently, it has been reported that miRNAs participate in multiple biological processes, such as development and immunity in humans and animals [@B9]-[@B14]. For example, it has been confirmed that miR-146 is a NF-κB-dependent gene, and suppresses the production of TNF-α and IL-1β in human and mice through targeting of the IRAK1 and TRAF6 genes. This suggests that miRNAs act as a key regulator of epithelial immune responses [@B15], [@B16]. Zhou et al. [@B17] reviewed that miRNAs may regulate epithelial immune responses in multiple steps of innate immune networks, including the production and secretion of inflammatory cytokines, chemokines, adhesion and co-stimulatory molecules. However, the roles of miRNAs in the modulation of immune and inflammatory responses to bacterial infection are not well understood in dairy cattle. Many studies have reported that the expression levels of many miRNAs detected by qPCR exhibit obvious changes in response to bovine mastitis or inflammatory pathway activation in bMECs. For example, it has been reported that the expressions of miRNAs (miR-223, miR-146a, miR-146b, miR-15a-3p, miR-15a-5p) were upregulated, whereas three miRNAs (miR-16a, -31, and -181a) were downregulated in infected versus healthy mammary tissue [@B11], [@B18], [@B19]. Although some reports have examined miRNAs and mastitis in dairy cows, the current understanding of the molecular mechanisms of the relationship is far from comprehensive. Thus, further investigation into the molecular mechanisms of the regulation of mastitis by miRNAs is necessary.

Increasingly, more robust techniques like high-throughput sequencing are being applied to detect the expression profile of known miRNAs, as well as to identify novel miRNAs. As a result, more information is becoming available to support our exploration of the expression and roles of miRNAs in the regulation of bovine mammary gland inflammation and their applications as biomarkers of mastitis.

It is well established that the cellular environment influences expression levels of intracellular genes, including miRNAs [@B20], [@B21]. However, few studies have been reported on transcriptomic differences in bovine mammary gland infected with *S. aureus* or *E. coli*. In the present study, in order to elucidate the differential expression miRNA (DIE-miRNA) and investigate the roles of miRNAs in host defenses against *S. aureus* or *E. coli*, 2 models of bovine mastitis were employed, using low dose exposures over an extended time frame to infect mammary glands of Chinese Holstein cows. Next, samples were sequenced and the miRNA profiles were compared. These data allowed for the detection of DIE-miRNA through the pairwise comparison of *S. aureus, E. coli*, and control groups. These findings provide a new understanding of the molecular mechanisms of mastitis in cows, and can guide further studies of pathogenesis of both *S. aureus* and *E. coli* type mastitis.

Materials and methods
=====================

Animals and ethics statement
----------------------------

A group of 2 year-old, half-sibling, Chinese Holstein cows in mid-lactation from rural regions of Yangling, Shannxi, China, were provided identical feed and management. All animals were allowed food and water *ad libitum*. Milk samples from each cow were tested for 3 weeks prior to the initiation of the trail to confirm that they contained \<200,000 somatic cells/mL, and were free of mastitis. All studies involving dairy cattle were performed using humane procedures according to the provisions of the Animal Husbandry and Use Committee of Northwest A & F University.

Induction of mastitis and sample collection
-------------------------------------------

*S. aureus* (ATCC 25923) or *E. coli* (ATCC 25922) (purchased from Shanghai Fuxiang Biotechnology Co., Ltd., China) were incubated on solid LB medium for 14 h at 37°C. A single colony was transferred to 2 mL of liquid LB medium and incubated for 7 h at 37°C. A 10 μL sample was transferred to 10 mL of liquid LB medium and incubated for 7 h (37°C). Serial dilutions were then made to prepare the desired inoculum dose of approximately 10^5^ CFU/mL. The cows were randomly divided into three groups (uninfected control group, *S. aureus* infected, and *E. coli* infected). The teats of each animal were cleaned and disinfected with 75% ethanol, then were directly injected into the mammary glands with a 5 mL suspension of either sterile PBS or 10^5^ CFU/mL *S. aureus* or *E. coli* through the teat canal, respectively. At 7 days, mammary tissues were surgically collected using aseptic technique. Pathological evaluation of H&E (hematoxylin-eosin) stained sections was conducted to ensure the successful induction of mastitis. These samples were used for RNA isolation, RNA-seq and qPCR verification.

RNA extraction
--------------

Total RNA was extracted from all samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s protocols. RNA purity was measured using the NanoPhotometer spectrophotometer (IMPLEN, CA, USA). RNA concentration and integrity were evaluated using the Qubit 2.0 Fluorometer (Life Technologies, CA, USA) and the Agilent Bioanalyzer 2100 system (Agilent Technologies, CA, USA), respectively.

Library preparation, clustering and sequencing for small RNA
------------------------------------------------------------

All RNA samples within each group were sent to BIOMARKER Biotechnology Co., LTD (Beijing, China) for small-RNA library construction and sequencing. The libraries were constructed as previously described [@B22], [@B23]. Briefly, a total of 1.5 μg RNA per sample was used for the construction of sequencing libraries. Library quality was assessed using the Agilent Bioanalyzer 2100. Clustering of the index-coded samples was carried out using a cBot Cluster Generation System according to the manufacturer\'s recommendations. Library preparations were then sequenced on an Illumina Hiseq 2500 platform (Illumina, Santa Clara, CA, USA) and paired-end reads were generated.

Quality control and miRNAs identification
-----------------------------------------

Raw data were first filtered using in-house perl scripts. During this process, clean reads were generated by removing low quality reads, as well as other reads consisting of the adapter and ploy-N reads from the raw data. Clean reads were obtained after being further trimmed by removing the inappropriate sequences with a length of \< 18 nt or \> 30 nt. Concurrently, Q20, Q30, GC-content and the sequence duplication level of the clean data were calculated for quality control of sequencing [@B22], [@B23]. All the following analyses were based on the resulting clean reads.

Using the Bowtie software, the clean reads were respectively aligned with the Silva, GtRNAdb, Rfam and Repbase databases to identify and filter out tRNA, rRNA, snRNA, snoRNA, as well as other ncRNA and repeats. The remaining reads were used to detect known and novel miRNAs as predicted using the miRDeep2 software package [@B24]. Briefly, all 3′-adapter trimmed sequences with a length of \<18 bp and mismatch \>1 were excluded from the analysis. The probability score of novel miRNAs were calculated. Those with a probability score of \>80% were considered to be true positives. The secondary structure of novel miRNA was predicted using the Randfold software.

Quantification of miRNA expression levels and differential expression analysis
------------------------------------------------------------------------------

MiRNA expression levels were estimated for each sample as follows: sRNAs were compared with the bovine genome, and the read count for each miRNA was obtained from the mapping results. The expression level of each gene was calculated according to the frequency of clean reads. The data were subsequently normalized to the number of transcripts per million clean tags (TPM) [@B25], using the following formula:

TPM = (specific miRNA reads ×1,000,000) / total miRNA mapped reads

Differential expression analyses of two samples were conducted using the IDEG6 software. *P*-values were corrected to q-values [@B26]. The significantly differentially expressed miRNAs were identified by the criteria of q-value \< 0.005, \|log2 (fold-change)\| ≥1 and FDR\< 0.01.

Target gene functional annotation
---------------------------------

Target genes of miRNAs of particular interest were predicted using miRnada [@B27] and RNAhybrid [@B28]. Functional annotations of miRNA target genes were performed by the following database searches: Nr (NCBI non-redundant protein sequences), Nt (NCBI non-redundant nucleotide sequences), KO (KEGG Ortholog database), GO (Gene Ontology).

GO enrichment analysis and KEGG Pathway Enrichment Analysis
-----------------------------------------------------------

Gene Ontology (GO) enrichment analysis of the target genes of DIE-miRNAs was applied using the GOseq R packages, which can adjust for gene length biases [@B29]. KEGG pathways were determined using the KOBAS software [@B30].

Verification of miRNA expression by qPCR
----------------------------------------

A total of 24 differentially expressed miRNAs, including 15 up-regulated and 9 down-regulated genes were validated by qPCR. The verification was designed and conducted in compliance with the MIQE (minimum information for publication of quantitative real-time PCR experiments) guidelines [@B31].

Total miRNA was extracted using the miRcute miRNA isolation kit (Tiangen Biotech Co., Ltd. Beijing, China) according to the manufacturer\'s instructions. No mammalian homologue cel-miR-39 (5′-UCACCGGGUGUAAAUCAGCUUG) was used to normalize the different RNA samples [@B13], [@B32], [@B33]. The procedures of qPCR for miRNAs were performed as previously described [@B13]. Briefly, a total of 5 μL of miRNA (625 ng) per sample was used to perform First-Strand cDNA Synthesis using the miRcute miRNA First-Strand cDNA Synthesis Kit (Tiangen Biotech Co., Ltd. Beijing, China) according to the manufacturer\'s instructions. Then, 1 μL of first-strand cDNA was used to perform the miRNA qPCR in an ABI 7500 Real-Time PCR System (Applied Biosystems, USA) using the miRcute miRNA qPCR Detection Kit (SYBR Green) (Tiangen Biotech Co., Ltd. Beijing, China) according to the manufacturer\'s instructions. Cel-miR-39 was used as a reference gene to normalize the expression of the miRNAs. The primers for this assay are listed in Table [S1](#SM0){ref-type="supplementary-material"}. At the end of the protocol, a dissociation melt curve of the products was determined. The amplification efficiency of the qPCR reactions for each gene (or primer pair) in this study were ranged from 99.6% to 104.3% with R^2^ \> 0.99 (data not shown). No-template control as well as no-reverse transcriptase control were included in all plates to verify the absence of contamination. All melt curves showed a single peak, indicating a single amplicon in each qPCR reaction. All amplifications were run in triplicate, and any questionable curves were excluded.

The expression levels of miRNAs were normalized to the mean of spiked-in miRNA cel-miR-39 and were calculated using the 2^-ΔΔCt^ method [@B34]. All data were expressed as mean ± SD. Statistical significance in the data was determined by the Student\'s *t*-test, with *P* values of \< 0.05 considered to be statistically significant.

Results
=======

Establishment of an *in vitro* bovine mastitis model
----------------------------------------------------

At 7 dpi with either*S. aureus* or *E. coli*, the infected cows exhibited clinical signs consistent with mastitis (redness, swelling, warmth and pain in the teats, fever, and flocculent precipitate in milk, and milk somatic cell counts \>2,000,000 cells/mL). These clinical signs indicated the mastitis model was successfully established. For confirmation of the clinical observations, H&E staining of mammary tissue biopsies was used to verify the development of mastitis. The results showed that pathological changes were evident in the *S. aureus* and *E. coli* infected compared to control group (Figure [1](#F1){ref-type="fig"}). Taken together, these observations indicate that mastitis was successfully induced.

miRNA sequencing
----------------

To study expression levels of miRNA in the mammary gland of dairy cattle during mastitis, three cDNA libraries of small RNAs were constructed from pooled total RNA for each group. Through sequencing of cDNA libraries using the Illumina Hiseq 2500 platform, 24,672,171, 18,365,120 and 19,677,779 raw reads were obtained from the control, *S. aureus*, and *E. coli* infected samples, respectively. After removal of low-quality reads, adaptor sequences, and reads with sequences \<18 nt or \>30 nt, an average of greater than 11.89 M of clean data per sample were obtained (Table [1](#T1){ref-type="table"}). This included 20,608,579, 15,600,273 and 16,681,613 clean reads (Q30 \> 94.37) from control, *S. aureus* and *E. coli* infected samples, respectively. Of these, 16,158,450 (78.41%), 12,552,468 (80.46%) and 13,650,442 (81.83%) clean reads of small RNAs from control and *S. aureus* and *E. coli* infected samples, respectively, were unannotated, including miRNA (Table [1](#T1){ref-type="table"}). Furthermore, the clean reads of all samples were compared with the bovine reference genome UMD3.1 (<http://www.ensembl.org/Bos_taurus/Info/Index>). The results showed that 13,048,593 (63%) clean reads of the control sample, 10,420,961 (67%) clean reads of *S. aureus* and 11,309,412 (68%) clean reads of the *E. coli* infected sample were able to be mapped to the bovine genome (Table [1](#T1){ref-type="table"}).

To determine the distribution of small RNAs, such as rRNA, tRNA, snRNA, snoRNA, ncRNA and miRNA, the Bowtie software was used to align the clean reads with the Silva, GtRNAdb, Rfam and Repbase databases. The results indicated that the miRNA reads in the control,*S. aureus* and *E. coli* infected groups were 12,209,865 (59.25%), 9,788,486 (62.74%) and 10,592,451 (63.50%), respectively (Figure [2](#F2){ref-type="fig"}).

In addition, the analysis was performed on the common sequence and specific sequences of small RNAs by pairwise comparisons of the three sets of sequencing data. The results are presented in Figure [3](#F3){ref-type="fig"}. With respect to the total number of sRNA sequence reads, most sequences (90.16%\~91.83%) were common among the groups, while a small proportion of the sequences (3.63%\~5.05%) were specific. For the total number of sequence types, the greatest proportion (40.18%\~44.90%) is specific, whereas a small proportion of the sequences (14.53%\~14.92%) were common. The above results suggest that the copy number of the specific sequence types between samples is much larger than that of the common sequence types.

Identification of miRNAs
------------------------

In the present study, the miRDeep2 software package [@B24] was used to detect known miRNAs, as well as to identify novel miRNAs. The Randfold tools software was used to predict the secondary structure of novel miRNAs. The results showed that there were, in total, 1838 miRNAs detected in the three groups, including 580 known-miRNAs and 1258 predicted novel miRNAs (Table [S2](#SM0){ref-type="supplementary-material"}). Among them, 1141 miRNAs were common among the 3 groups, while 85 miRNAs, 129 miRNAs, and 158 miRNAs were specific in control, *S. aureus* infected, and*E. coli* infected groups, respectively (Figure [4](#F4){ref-type="fig"}).

Results of length distribution of the mapped miRNAs indicated that the majority of the mapped known miRNAs and novel miRNAs were 20 to 24 nucleotides in length (comprising 97.58%\~97.77% and 84.94%\~86.62% of their total number, respectively). The length of the majority of known or novel miRNAs was 22 nucleotides, followed by 23, 21, 20 or 24 nucleotides (Figure [5](#F5){ref-type="fig"}).

Analysis of miRNA expression
----------------------------

The expression level of miRNAs were calculated based on the frequency of clean tags, and were subsequently normalized to TPM [@B25]. The overall expression pattern of miRNAs in the samples is presented in Figure [6](#F6){ref-type="fig"}. It can be seen that the miRNA expression within the three samples are highly consistent (Figure [6](#F6){ref-type="fig"} A). In comparison to the control group, the overall expression levels in the infected groups were similar, indicating that both *E. coli* and *S. aureus* infection had similar effects on the expression of miRNAs in dairy cows (Figure [6](#F6){ref-type="fig"} B). Furthermore, the most abundant miRNAs (at least one group of TPM \> 1,000) are presented in Table [S3](#SM0){ref-type="supplementary-material"}. The top 10 most highly expressed miRNAs among all of the samples were bta-miR-148a, bta-miR-143, bta-miR-21-5p, bta-miR-26a, bta-miR-30a-5p, bta-miR-99a-5p, bta-let-7f, bta-let-7g, bta-miR-10b and bta-miR-126-3p. In addition, the novel miRNA conservative_X\_30752 (the sequence is presented in Table [S4](#SM0){ref-type="supplementary-material"}) was the most highly expressed miRNA in mammary gland tissues of all samples.

DIE-miRNAs in mammary glands of infected animals
------------------------------------------------

The expression levels of miRNAs were compared between the *S. aureus* or *E. coli* infected groups in relation to the control group in order to identify DIE-miRNAs. Based on the criteria of a two-fold or greater change, FDR\<0.01, and TPM\>1, a total of 279 DIE-miRNAs were identified, with 186 being up-regulated and 93 down-regulated, between the *S. aureus*-infected and control groups (Figure [7](#F7){ref-type="fig"}, Table [S5](#SM0){ref-type="supplementary-material"}). Among them, 173 were known miRNAs, whereas 106 were predicted novel miRNAs. It is worth noting that bta-miR-7863 was not detected in the control sample, however, in the *S. aureus* infected group, expression increased more than 24-fold. This suggests that bta-miR-7863 could be a sensitive biomarker of *S. aureus* mastitis. Many known miRNAs (including bta-miR-184, bta-miR-223, bta-miR-2344, bta-miR-147, bta-miR-665, bta-miR-370, bta-miR-9-5p, bta-miR-214, bta-miR-154c, bta-miR-27a-5p, bta-miR-493, bta-miR-494, bta-miR-155, bta-miR-221, bta-miR-146a, bta-miR-199a, bta-miR-378, etc.) as well as three novel miRNAs (conservative_14_6048, conservative_21_15256, conservative_X\_30874) (Table [S4](#SM0){ref-type="supplementary-material"}) were stably and highly expressed in bovine mammary glands. It was observed that these miRNAs were further significantly up-regulated in *S. aureus* infected animals. Moreover, in comparison to the control, many of the known miRNAs, including bta-miR-375, bta-miR-885, bta-miR-6522, bta-miR-6516, bta-miR-2285t, bta-miR-29, bta-miR-30, bta-miR-200, etc., were significantly down-regulated. For example, bta-miR-375, bta-miR-885, and bta-miR-6522, were the most down-regulated miRNAs (3.4\~6.2 fold change). The expression of novel miRNA conservative_26_19257 was significantly decreased (9.2-fold change) in the *S. aureus* infected group (Table [S5](#SM0){ref-type="supplementary-material"}).

In response to experimental *E. coli* infection, a total of 305 DIE-miRNAs were detected, with 243 being up-regulated and 62 down-regulated, in comparison to the control group (Figure [7](#F7){ref-type="fig"}, Table [S6](#SM0){ref-type="supplementary-material"}). Among the up-regulated miRNAs, 2 known miRNAs (miR-202, miR-2357) were only detected in *E. coli* infected samples, making them promising biomarkers for *E. coli* induced mastitis in cattle. Moreover, 6 miRNAs (miR-7863, miR-1247-3p, miR-541, miR-2320-5p, miR-431, and miR-2448-5p) were detected in both *E. coli* and *S. aureus* infected samples, suggesting these miRNAs have similar roles in the regulation of mastitis induced by the 2 types of bacterium.

Comparative analysis of DIE-miRNAs between *S. aureus* and *E. coli* infected mammary glands
--------------------------------------------------------------------------------------------

It is well established that both *S. aureus* and*E. coli* cause mammary inflammation. However, the former is Gram-positive bacteria, the latter is Gram-negative bacteria. In order to investigate the differences in the molecular mechanism of mastitis caused, we compared the DIE-miRNAs of M.C (control, healthy mammary gland) vs M.S (*S. aureus* infected mammary gland) and M.C vs M.E (*E. coli* infected mammary gland). The data indicated that 197 DIE-miRNAs are identical, 108 DIE-miRNAs are specific to *E. coli*, and 82 DIE-miRNAs are specific to *S. aureus*. Surprisingly, it was observed that bta-miR-144 and bta-miR-451 were significantly up-regulated in *S. aureus* infected mammary glands, but were significantly down-regulated in *E. coli* infected mammary glands (Table [S5](#SM0){ref-type="supplementary-material"}, S6, and Figure [7](#F7){ref-type="fig"}C), suggesting that they play different roles in the regulatory mechanisms of mastitis caused by*S. aureus* and *E. coli*.

When the DIE-miRNAs of the *S. aureus* and *E. coli* infected groups were compared, it was observed that 70 up-regulated and 21 down-regulated DIE-miRNAs were uniquely identified in the *E. coli* mastitis samples compared with those of*S. aureus* mastitis (Table [S7](#SM0){ref-type="supplementary-material"}). These results suggest that different miRNAs exert different molecular functions with respect to inflammatory responses in mammary glands caused by different pathogens, namely *E. coli* and *S. aureus*.

Verification of differentially expressed miRNAs by qPCR
-------------------------------------------------------

To verify the results of the deep sequencing and comparative analyses, we randomly selected 24 miRNAs for qPCR confirmation: 5 up-regulated and 3 down-regulated from the three comparisons of M.C vs M.S, M.C vs M.E and M.E vs M.S. As is presented in Figure [8](#F8){ref-type="fig"}, the qPCR detection of the DIE-miRNAs were consistent with those identified through RNAseq, confirming the reliability of our DIE-miRNAs data.

Functional annotation and KEGG pathway enrichment analysis of DIE-miRNA target genes
------------------------------------------------------------------------------------

To better understand the roles of the identified DIE-miRNAs in bovine mammary glands, the target genes of DIE-miRNAs were predicted. The results revealed a total of 18,385 target genes of the 305 DIE-miRNAs of M.C vs M.E, and 18,399 target genes of the 279 DIE-miRNAs of M.C vs M.S. The predicted target genes were divided into 6 groups, including genetic information processing, organismal systems, disease, metabolism, cellular processes, and environmental information processing. The top 6 clusters observed were as follows: olfactory transduction, neuroactive ligand-receptor interaction, cytokine-cytokine receptor interaction, MAPK signalling pathway, endocytosis and pathways in cancer (Figure [9](#F9){ref-type="fig"}). It is interesting and supportive of our findings that many immune signalling pathways are included, such as TLR signalling pathway, cell adhesion molecules, MAPK signalling pathway, TGF-β signalling pathway, leukocyte trans endothelial migration, cytokine-cytokine receptor interaction, and chemokine signalling pathways. Thus, it can be inferred that DIE-miRNAs likely participate in the immune response through regulation of their target genes.

Discussion
==========

RNAseq technologies have enabled the discovery of novel miRNAs, the detection of those expressed at low levels in a high-throughput system, as well as the detection of differentially expressed miRNAs [@B35], [@B36]. In the case of bovine mastitis, at the time of publication, a limited number of studies have applied these approaches to study the expression patterns and roles of miRNAs. Lawless et al. [@B36] used the Illumina HiSeq 2000 platform to detect 21 significant differentially expressed miRNAs in response to *Streptococcus uberis* infected bMECs. Jin et al. [@B35] detected 113 novel miRNAs, and identified 10 and 10 differentially expressed miRNAs in*E. coli* and *S. aureus* challenged bMECs, respectively. However, the study of bMECs alone cannot fully reveal the molecular mechanisms of mammary gland infection due to the relative lack of complexity compared to *in vivo* models of mastitis. Immune cells in tissues are also involved in the regulation of the mammary gland inflammatory response process. With respect to bovine mammary tissues, only one study to date has utilized solexa sequencing to detect the differential expression of miRNAs in response to high dose (5 mL suspension of 10^7^ CFU/mL *S. aureus*) and short-term (24 hpi) *S. aureus* infection [@B37]. However, mastitis is a gradual process of repeated infections with low dose pathogens in the dairy industry. Therefore, we sought to investigate the function of miRNA in an *in vivo* model of mastitis caused by either *S. aureus* or *E. coli*, that most closely resembles natural disease progression. The mastitis models employed here were induced in dairy cows with a single low dose infection of *E. coli* or *S. aureus,* which slowly develops into mastitis. Mammary glands presenting with mastitis were sequenced using RNAseq technology to estimate the expression of miRNAs. In this study, 580 known miRNAs and 1258 predicted miRNAs were detected in the infected mammary glands of dairy cattle. Of these, 74 were very highly expressed (TPM \> 1,000) (Table [S3](#SM0){ref-type="supplementary-material"}), suggesting their relative importance in the development of inflammation in the bovine mammary gland.

Although DIE-miRNAs in mammary tissue challenged with a high dose *S. aureus* have been previously reported [@B37], our results differed slightly with respect to the quantities and types of DIE-miRNAs, suggesting that dose if the bacterial inoculum, or the duration of infection can affect the expression of miRNAs in mammary glands. Therefore, the current study contributes additional useful information with regard to the molecular regulation of mastitis in dairy cows. The expression patterns of miRNAs in control and *S. aureus* infected groups included a total of 279 DIE-miRNAs includes 186 up-regulated and 93 down-regulated ones (Figure [7](#F7){ref-type="fig"}, Table [S5](#SM0){ref-type="supplementary-material"}). Furthermore, a total of 305 DIE-miRNAs, including 243 up-regulated and 62 down-regulated, were identified in *E. coli* infected samples compared with controls (Figure [7](#F7){ref-type="fig"}, Table [S6](#SM0){ref-type="supplementary-material"}). Of these DIE-miRNAs, it appears as though bta-miR-7863 might be a specific biomarker of the two types of mastitis examined here due to the expression between the *S. aureus* and *E. coli* infected groups increased by 24-fold over the control group. The potential target genes predicted by the bioinformatics analysis showed that bta-miR-7863 might regulate multiple immune-related genes, including members of the interleukin family, IRAK1, TLR7, LBP, ect., which are key molecules of the animal immune system (Table [S8](#SM0){ref-type="supplementary-material"}). Moreover, miRNAs with high expression levels in the control and *S. aureus* infected groups, including bta-miR-223, bta-miR-146a, bta-miR-184, bta-miR-155, bta-miR-214, bta-miR-147 and bta-miR-378, were also differentially expressed in both groups. The expression levels of many of the miRNAs characterized in this study were consistent with findings reported in other previous studies. For example, several studies reported that the expressions of bovine miR-223 in mammary gland with mastitis was up-regulated in comparison to that of healthy cows [@B18], [@B37], [@B38], and have also been observed to regulate the mammary innate immune response by directly targeting HMGB1 [@B39]. Furthermore, our previous study identified that the expression of bovine miR-146a was significantly increased in bovine mammary tissues from cases of mastitis caused by *S. aureus*, *E. coli* or mixed bacterial infection [@B11], and supports the idea that bovine miR-146a regulates the secretion of inflammatory cytokines such as TNF-α, IL-6, and IL-8 in bMECs [@B13]. It is also noteworthy that bta-miR-375 is one of most down-regulated DIE-miRNAs (6.20 and 4.67-fold change in*S. aureus* and *E. coli* infected mammary tissue, respectively), suggesting that it participates in the regulation of immune responses and inflammation. However, very little information has been reported on the function of bta-miR-375 in bovine immunity, and comprehensive studies are required to elucidate its role in the regulation of bovine mammary inflammation.

In this study, we first compared the DIE-miRNAs of M.C vs M.S and M.C vs M.E. The observed results showed that most DIE-miRNAs are identical between the two datasets, and a small number of DIE-miRNAs is unique to each group. This indicates that these DIE-miRNAs function among a common or specific regulatory pathway in the immune system in response to bovine mastitis following *E. coli* and *S. aureus* infection. Moreover, we observed that expression changes of bta-miR-144 and bta-miR-451 in the two groups were opposite of each other (up-regulated in *S. aureus* infected mammary gland, while down-regulated in *E. coli* infected mammary gland), suggesting that they play different roles in the mechanisms regulating the two types of mastitis examined here. Sontakke et al. [@B40] reported that bta-miR-144 and bta-miR-451 were up-regulated in large healthy follicles relative to small follicles. However, there are no reports at the time of publication regarding their expression and regulatory functions in mastitis. In order to explore their roles, potential target genes were predicted using bioinformatics analyses. The results indicated that bta-miR-451 might regulate ATF2, CDKN2D and MEF2D (Table [S8](#SM0){ref-type="supplementary-material"}). Interestingly, it had been reported that human miR-451 (has-miR-451) directly target the 3′UTR of the ATF2 gene [@B41], in addition to regulating inflammatory cytokine secretion in rheumatoid arthritis [@B42]. Meanwhile, the MEF2D gene was demonstrated to be involved in regulating inflammatory responses [@B43], [@B44]. As far as bta-miR-144 is concerned, total of 31 potential target genes involved in immunity, such as EZH2, NKRF, and so on (Table [S8](#SM0){ref-type="supplementary-material"}), are predicted. Several studies have reported that the role of EZH2 is the regulation of the differentiation and function of T cells [@B45], as well as in negatively regulating immune responses [@B46]. Moreover, NKRF inhibits the activity of NF-κB, and subsequently regulates the NF-κB signaling pathway, which is the key signaling pathway of the innate immune response [@B47], [@B48]. According the results of bioinformatics analysis, we speculate that bta-miR-144 and bta-miR-451 might participate in the regulation of immune responses. Thus, comprehensive studies of the immunological functions of bta-miR-144 and bta-miR-451 are needed to reveal the significant differences in the immune regulatory mechanisms responsive to *S. aureus* and*E. coli* infections.

To investigate the regulatory function of DIE-miRNAs in dairy cattle, we predicted potential targets of these miRNAs. Among the putative targets, bta-miR-146a and bta-miR-214 were identified to control genes responsible for regulating inflammation in bovine mammary epithelial cells [@B11]-[@B13]. In the present study, the putative target genes of DIE-miRNAs were annotated as being involved in various classes of immune signalling pathways, TLR signalling pathway, TGF-β signalling pathway, cytokine-cytokine receptor interaction, MAPK signalling pathway, cell adhesion molecules, leukocyte trans endothelial migration, and chemokine signalling pathways. It has been previously reported that these signalling pathways described above are likely associated with the development of mastitis [@B3], [@B49]-[@B51]. The functions of the putative targets and the corresponding miRNAs\' role in the regulation of mammary inflammation indicate that the DIE-miRNAs may play multiple roles in immunity related gene regulation networks.

In summary, we detected the miRNAs expressed in bovine mammary glands infected with *S. aureus* or *E. coli*, and identified 580 known miRNAs and 1258 novel miRNAs. Furthermore, 279 DIE-miRNAs were identified in *S. aureus* infected mammary glands, and 305 DIE-miRNAs in E. coli infected mammary gland. These miRNAs might be involved in the regulation of various immune signaling pathways, including TLR signaling pathways, MAPK signaling pathway, cell adhesion molecules, TGF-β signaling pathway, cytokine-cytokine receptor interactions, leukocyte trans endothelial migration, and chemokine signaling pathways, according the KEGG pathway enrichment analysis of target genes of the detected DIE-miRNAs. Furthermore, many DIE-miRNAs, such as bta-miR-144, bta-miR-451 and bta-miR-7863, might be biomarkers of the two types of mastitis examined here. This study provides an experimental basis for revealing underlying causes and regulatory mechanisms leading to the development of mastitis. We also uncovered a potential role for miRNAs as biomarkers in the diagnosis of mastitis, as well as for the development of control measures.
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miRNAs

:   MicroRNAs

*E. coli*

:   *Escherichia coli*

*S. aureus*

:   *Staphylococcus aureus*

CFU

:   Colony-Forming Units

DIE-miRNAs

:   differentially expressed miRNAs

dpi

:   days post-infection

hpi

:   hours post-infection

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

GO

:   Gene Ontology

TLR

:   Toll-like receptor

MAPK

:   bMECs: bovine mammary epithelial cells

qPCR

:   quantitative real-time PCR

TPM

:   the number of transcripts per million clean tags

M.C

:   control, healthy mammary gland

M.S

:   *S. aureus* infected mammary gland

M.E

:   *E. coli* infected mammary gland

*S. uberis*

:   *Streptococcus uberis*

IRAK1

:   interleukin-1 receptor-associated kinase 1

TLR7

:   toll-like receptor 7

LBP

:   lipopolysaccharide binding protein

ATF2

:   activating transcription factor 2

CDKN2D

:   cyclin-dependent kinase inhibitor 2D

MEF2D

:   myocyte enhancer factor 2D

EZH2

:   enhancer of zeste homolog 2

NKRF

:   NF-κB repressing factor.

![HE staining of mammary gland tissue (200×). (A) Control; (B) *E. coli*; (C)*S. aureus*. Comparing with (A), (B) and (C) have a few pathological changes, including disruption of the lobular structure of the mammary gland, separation of the mammary epithelial cells, reduced size of acinar cavities, damaged mammary gland acini, as well as inflammatory infiltrates including neutrophils and macrophages.](ijbsv14p0087g001){#F1}

![Distribution of small RNAs among different categories in the three treatment groups. The numbers in parentheses indicate the read numbers for each type of small RNA.](ijbsv14p0087g002){#F2}

![Venn diagram representation of the statistics of common and specific sequences of small RNAs between samples. (A) Control mammary tissue (M.C) vs *E. coli* infected mammary tissue (M.E); (B) Control mammary tissue (M.C) vs *S. aureus* infected mammary tissue (M.S); (C) *S. aureus* infected mammary tissue (M.S) vs *E. coli* infected mammary tissue (M.E). Uniq_sRNA means type of sRNA sequences, total_sRNA means quantity of sRNA sequences.](ijbsv14p0087g003){#F3}

![A representation of the number of all miRNAs overlapping in different comparisons](ijbsv14p0087g004){#F4}

![Length distribution of the mapped miRNAs in mammary glands of cows](ijbsv14p0087g005){#F5}

![The overall distribution of miRNA expression in each group. (A) TPM density distribution. The curves of different colours represent the different experimental samples. The abscissa of the points on the curve represents the logarithm of TPM of miRNA in the corresponding sample, and the ordinate of the point represents the probability density. (B) Comparison of correlation between samples, which measured with Pearson correlation coefficient as calculated by the TPM of miRNA.](ijbsv14p0087g006){#F6}

![Differential expression of miRNAs (DIE-miRNAs) among samples. (A) The plot showing the expression levels of DIE-miRNAs. The differential expression of each point in the volcanic map represents a miRNA, the abscissa represents a logarithmic value of a difference in expression between the two samples; the ordinate represents -log(FDR). The greater the absolute value of the abscissa, the greater the difference in the expression between the two samples. The greater the ordinate value, the more significant the difference, and the more accurately the miRNAs were screened. The blue plots in the figure represents miRNAs that are not differentially expressed, the red dots represent up-regulated miRNAs, and the green points represent down-regulated miRNAs. (B) Clustering analysis of expression pattern of DIE-miRNAs among the three groups. (C) Comparison of the number of DIE-miRNAs between *S. aureus* and *E. coli* infected samples compared with controls, respectively. The heatmap is based on the log~2~^TPM^ of each DIE-miRNA. M.C, control sample (Healthy mammary gland); M.E, *E. coli* infected mammary gland; M.S, *S. aureus* infected mammary gland.](ijbsv14p0087g007){#F7}

![Expression pattern validation of miRNAs selected from the DIE analysis of RNAseq by qPCR. The relative expression level (Fold change=Log2 Ratio) of each miRNA was normalized to the spiked-in cel-miR-39.](ijbsv14p0087g008){#F8}

![KEGG pathway annotation of DIE-miRNA target genes](ijbsv14p0087g009){#F9}

###### 

Overview of miRNA sequencing data

  Samples       Raw reads    Q30 (%)   Clean reads            Annotated reads^a^   Unannotated reads^b^   Mapped Small RNA Reads
  ------------- ------------ --------- ---------------------- -------------------- ---------------------- ------------------------
  Control       24,672,171   94.37     20,608,579 (100.00%)   4,450,129 (21.59%)   16,158,450 (78.41%)    13,048,593 (63%)
  *S. aureus*   18,365,120   94.57     15,600,273 (100.00%)   3,047,805 (19.65%)   12,552,468 (80.46%)    10,420,961 (67%)
  *E. coli*     19,677,779   94.46     16,681,613 (100.00%)   3,031,171 (18.17%)   13,650,442 (81.83%)    11,309,412 (68%)

^a^ Annotated reads include rRNA, tRNA, snRNA, snoRNA, ncRNA, repbase.

^b^ miRNAs are contained in unknown unannotated reads.

[^1]: ^\*^ These authors contributed equally to this work.
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